Tempest Therapeutics, Inc. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
Tempest Therapeutics, Inc. (TPST) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals of $352.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals · last filed 2021-03-29
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $352.00K.
- 2019-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $414.00K.
- 2018-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $1.23M.
- 2017-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $260.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals |
|---|---|
| 2020-12-31 | $352.00K 10-K · filed 2021-03-29 |
| 2019-12-31 | $414.00K 10-K · filed 2021-03-29 |
| 2018-12-31 | $1.23M 10-K · filed 2020-03-11 |
| 2017-12-31 | $260.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |